Advertisement

ASO Author Reflections: Clinical Value of PET-CT for Gastric Cancer

  • Michihiro Kudou
  • Toshiyuki Kosuga
ASO Author Reflections
  • 36 Downloads

Notes

Disclosure

The authors declare that they have no conflict of interest.

References

  1. 1.
    Sasako M, Sakuramoto S, Katai H, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29(33):4387–93.CrossRefGoogle Scholar
  2. 2.
    Fukagawa T, Katai H, Mizusawa J, et al. A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A). Gastric Cancer. 2018;21(1):68–73.CrossRefGoogle Scholar
  3. 3.
    Kudou M, Kosuga T, Kubota T, et al. Value of preoperative PET-CT in the prediction of pathological stage of gastric cancer. Ann Surg Oncol. 2018;25(6):1633–9.CrossRefGoogle Scholar
  4. 4.
    Shimada H, Okazumi S, Koyama M, Murakami K. Japanese Gastric Cancer Association task force for research promotion: clinical utility of 18F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature. Gastric Cancer. 2011;14(1):13–21.CrossRefGoogle Scholar
  5. 5.
    Mocellin S, Pasquali S. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. Cochrane Database Syst Rev. 2015;2:Cd009944.Google Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Division of Digestive Surgery, Department of SurgeryKyoto Prefectural University of MedicineKyotoJapan

Personalised recommendations